Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

At 6.3% CAGR, Acne Treatment Market Anticipated to Reach 19.03 Billion, globally by 2028, says Brandessence Market Research

This image opens in the lightbox

News provided by

Brandessence Market Research And Consulting Private Limited

11 Jan, 2022, 12:30 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, Jan. 11, 2022 /PRNewswire/ -- According to Brandessence Market Research, the Acne Treatment Market size reached USD 12.41 Billion in 2021. The Acne Treatment market is likely to grow at robust CAGR of 6.3%, and reach size of USD 19.03 Billion by 2028 end.

This Report is Mainly Focusing On Bellow Acne Treatment Companies:

  • ALLERGAN
  • Stiefel Laboratories, Inc.
  • Galderma S.A.
  • Johnson & Johnson Services, Inc.
  • Valeant
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline Plc.
  • Roche Holding AG
  • Bayer AG

Get Sample Copy of This Premium Report@ https://brandessenceresearch.com/requestSample/PostId/611

Patients suffering from Acne account for eight largest group of diseased patients worldwide. The findings published in the Global Burden of Disease Project, created by the University Of Washington School Of Medicine, also reveals some other promising insights. The university findings note that skin diseases of all types, increased Disability Adjusted Life Years (DALY) by 8% in Canada, during 1990-2017.  It also increased Mortality Adjusted Life years (YLL) by 4%, and Years Lived With Disability (YLD) by 8%. Acne continues to remain a debilitating conditions for many, with as many as 50 million people affected in key regions like the US. In 2013, the American Academy of Dermatology Association estimated that the conditions led to USD 1.2 billion in costs, due to treatment and lost productivity. Furthermore, 5.1 million patients opted for medical treatment for acne in 2013, with primary patients being young adults, and children. Growing awareness about impact of Acne on self-esteem, socio-economic status, and life in general remains a key driver of growth globally. 

Acne Treatment Market report is segmented on the basis of type, By Treatment Modality, By End User, By Medication, By Therapeutic Devices and region & country level.

By Type:

  • Cystic Acne
  • Inflammatory Acne
  • Post-Surgical/Wound Acne

By Treatment Modality:

  • Oral
  • Topical

By End User:

  • Hospitals
  • Clinics

By Medication:

  • Retinoid
  • Antibiotics

By Therapeutic Devices:

  • Lasers
  • Microdermabrader
  • Dermabradors
  • Others

Acne Treatment Market: Covid-19 Impact 

The covid-19 had an adverse impact on the growth of the acne treatment market, despite the fact that globally, pharmacies remained open. Like the treatment many other diseases, covid-19 pandemic delayed treatment, while simultaneously disrupting supplies. The year 2020 witnessed resurgence of growth in the acne treatment market, with non-surgical acne related treatments like full field ablative, witnessing tremendous growth. For example, in 2020, the treatment resulted in 225,141 non-surgical procedures globally. The figure rose from 190,978 non-surgical procedures globally in 2019, marking a promising 17.9% growth.

Get Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/611

Acne Treatment Market: Opportunity Analysis   

Europe remains the most important market in the global acne treatment market. The region accounted for €76.7 billion in revenues in cosmetic retail sales in 2020. Countries like Germany, France, UK, Italy, Spain, and Poland remain largest contributor to its growth, while Germany leads with €14 billion in revenues. Animal testing and increased demand for natural ingredients pose some concerns to growth in this region. However, increased funding for research and development promise growing alternatives to animal testing. According to Cosmetics Europe, an industry association, modest estimates put the total R&D funding of European cosmetic manufacturers at €2.35 billion in 2017. Major cosmetic companies in the European region spend an average of 5% on R&D, as part of their annual turnover.  Growing demand in key regions like Europe, and increased interest in R&D to fuel launch of new cosmetic products remain promising drivers of growth in the acne treatment market.

Acne Treatment Market: Notable Development

Sanofi, a key global vaccine manufacturer acquired Origimm Biotechnology, a company specializing in skin disease, in December 2021. The acquisition is important development in the acne treatment market, because it may introduce a vaccine-based acne treatment to current repertoire of established treatments.  The acquisition agreement is expected to provide Sanofi with the licensing rights to ORI-001, a therapeutic vaccine to treat acne vulgaris. The vaccine based on recombinant protein, entered primary clinical study in third quarter of 2021. Sanofi is expected to leverage its own messenger RNA platform to prepare the vaccine for further trials, before the final approval.

On Special Requirement Acne Treatment Market Report is also available for below region:

North America

  • U.S, Canada

Europe

  • Germany, France,U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe

Asia-Pacific

  • South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC,

Latin America

  • Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

  • Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA

Get Full Access of all Report: https://brandessenceresearch.com/medical-device/acne-treatment-market-size-and-share

Related Reports:

  • Global Industrial Hemp Market Accounted for USD 3.91 Bn in 2020
  • Global Molecular Diagnostics Market Size Expected to Reach USD 32.08 Billion by 2027
  • Bearing Market Forecast and Analysis report categorizes global market by Application and Forecast to 2028
  • ADAS Market Size Expected to Reach 50.55 Billion, globally by 2028
  • In-Car Infotainment Market Size is Expected to Reach USD 36.30 Billion in 2028
  • Global Conductive Inks Market Size to hit USD USD 3757.3 Mn by 2027
  • Global Endpoint Security Market USD 21.18 Bn by 2027
  • Prosthetics Market Size to hit USD 12.40 Bn by 2025
  • Electric Bikes Market Size to hit USD 95.48 Bn in 2027
  • Electric Motors Market Size to hit 193.64 billion by 2027

i-Factor: Live Market intelligence platform

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic.  Register for free trail here @ https://brandessenceresearch.com/i-factor/login/userRegister

Brandessence Market Research & Consulting Pvt ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Website: https://brandessenceresearch.com 

Blog: Radiopharmaceuticals Companies 

Follow Us: LinkedIn

Mr. Vishal Sawant 
Email:
 vishal@brandessenceresearch.com 
Email: Sales@brandessenceresearch.com 
Corporate Sales: +44-2038074155
Asia Office: +917447409162

Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.